SCHEMBL13713051

SCHEMBL13713051

C[C@@H](OCC(=O)NC1CC1)n1cnc2c(N)nc(C#CCC3CCN(C(=O)Oc4ccc(Cl)cc4)CC3)nc21

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 3/20 0.51
▸ ATF4 P18848 3/20 0.38
▸ ADORA3 P0DMS8 2/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ CCNB2 O95067 1/20 0.33
▸ CDK1 P06493 1/20 0.33
▸ CCNB1 P14635 1/20 0.33
▸ CDK5 Q00535 1/20 0.33
▸ CCNB3 Q8WWL7 1/20 0.33
▸ CCNE2 O96020 3/20 0.33
▸ CCNA2 P20248 3/20 0.33
▸ CCNE1 P24864 3/20 0.33
▸ CDK2 P24941 3/20 0.33
▸ CCNA1 P78396 3/20 0.33
▸ ADORA2B P29275 1/20 0.32
▸ CASP3 P42574 1/20 0.32
▸ FAAH O00519 1/20 0.31
▸ MCHR1 Q99705 1/20 0.31
▸ KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13626210 0.85 ADORA2A (0.45) ADORA2AADORA3ADORA1CCNB2CDK1
SCHEMBL13713096 0.85 ADORA2A (0.50) ADORA2AADORA3ADORA1
SCHEMBL12789751 0.81 ADORA2A (0.44) ADORA2AADORA3ADORA1CCNB2CDK1
SCHEMBL13713198 0.81 ADORA2A (0.47) ADORA2AADORA3ADORA1CCNB2CDK1
SCHEMBL12153399 0.81 ADORA2A (0.47) ADORA2AADORA3ADORA1ADORA2B
SCHEMBL13713048 0.81 ADORA2A (0.49) ADORA2AADORA3ADORA1KMT2A
SCHEMBL13713097 0.80 ADORA2A (0.47) ADORA2AADORA3ADORA1
SCHEMBL13021005 0.80 ADORA2A (0.57) ADORA2AADORA3ADORA1
SCHEMBL13625739 0.80 ADORA2A (0.45) ADORA2AADORA3ADORA1
SCHEMBL13626222 0.80 ADORA2A (0.47) ADORA2AADORA3ADORA1CCNB2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7589076-B2 Substituted aryl piperidinylalkynyladenosines as A2AR agonists PGX HEALTH, LLC (US) 2009-09-15 — — US disclosed
Send feedback